Science Joins Push to Screen Statistics in Papers
By Richard Van Noorden,
Nature News
| 07. 03. 2014
Untitled Document
The journal Science is adding an extra round of statistical checks to its peer-review process, editor-in-chief Marcia McNutt announced today. The policy follows similar efforts from other journals, after widespread concern that basic mistakes in data analysis are contributing to the irreproducibility of many published research findings.
“Readers must have confidence in the conclusions published in our journal,” writes McNutt in an editorial today1. Working with the American Statistical Association, the journal has appointed seven experts to a statistics board of reviewing editors (SBoRE). Manuscript will be flagged up for additional scrutiny by the journal’s internal editors, or by its existing Board of Reviewing Editors (more than 100 scientists whom the journal regularly consults on papers) or by outside peer reviewers. The SBoRE panel will then find external statisticians to review these manuscripts.
Asked whether any particular papers had impelled the change, McNutt said: “The creation of the [statistics board] was motivated by concerns broadly with the application of statistics and data analysis in scientific research and is part of Science’s overall drive to increase...
Related Articles
By Judith Levine, The Intercept | 04.04.2024
WHEN THE ALABAMA Supreme Court ruled that fertilized embryos were “extrauterine children,” it did more than imperil the future of in vitro fertilization in Alabama and, potentially, the U.S. The ruling, on the claimed “wrongful death” of frozen embryos...
By Todd Feathers, The Guardian | 03.25.2024
For the last several months, a city at the heart of Silicon Valley has been training artificial intelligence to recognize tents and cars with people living inside in what experts believe is the first experiment of its kind in the...
By Sarah Zhang, The Atlantic | 03.18.2024
People are discovering the truth about their biological parents with DNA—and learning that incest is far more common than many think.
When Steve Edsel was a boy, his adoptive parents kept a scrapbook of newspaper clippings in their bedroom closet...
By Antonio Regalado, MIT Technology Review | 03.20.2024
There is a new most expensive drug ever—a gene therapy that costs as much as a Brooklyn brownstone or a Miami mansion, and more than the average person will earn in a lifetime.
Lenmeldy is a gene treatment for metachromatic...